← Back to Search

Behavioral Intervention

Sensory Training for Chronic Pain

N/A

Recruiting

Led By Laura Simons, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of musculoskeletal pain including chronic regional pain syndrome

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, discharge (at 8 weeks), and follow up (1-month)

Awards & highlights

Study Summary

This trial tests if a video game-like therapy can help kids with chronic pain.

Who is the study for?

This trial is for children with chronic musculoskeletal pain, such as chronic regional pain syndrome. Participants must speak English but cannot have neurological conditions like seizures or cerebral palsy, severe mood disorders like major depression/anxiety, or skin diseases/allergies aggravated by sensor tape.Check my eligibility

What is being tested?

The study is testing a gamified sensory rehabilitation training technology to see if it's practical and well-received by kids suffering from long-term muscle and joint pain.See study design

What are the potential side effects?

Since this trial involves non-invasive sensory training technology, side effects are minimal but may include discomfort or skin irritation due to the use of sensor tape on sensitive skin.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with chronic pain in my muscles or joints.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline through discharge (at 8 weeks) weekly and follow up (1-month)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline through discharge (at 8 weeks) weekly and follow up (1-month)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through discharge (at 8 weeks) weekly and follow up (1-month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the Intervention- Net Promoter Score

Acceptability of the Intervention- Qualitative Interview

Acceptability of the Intervention- Theoretical framework of acceptability (TFA) Questionnaire

+1 more

Secondary outcome measures

Bodily Threat Monitoring Scale (BTMS)

Brief Pain Inventory Short Form (BPI)

Child Pain Acceptance Questionnaire (CPAQ)

+4 more

Other outcome measures

Adverse events

Treatment Expectancy and Credibility (TEC)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Sensory TrainingExperimental Treatment1 Intervention

Daily protocol - gamified sensory training

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,325 Total Patients Enrolled

36 Trials studying Chronic Pain

9,208 Patients Enrolled for Chronic Pain

Laura Simons, PhDPrincipal InvestigatorStanford University

3 Previous Clinical Trials

158 Total Patients Enrolled

3 Trials studying Chronic Pain

158 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could patients still join this research initiative?

"The data on clinicaltrials.gov affirms that this medical experiment is now recruiting new participants. It was initially announced October 16th 2023, and the most recent update was November 16th 2023."

Answered by AI

Is geriatric eligibility a factor in this research endeavor?

"This medical experiment is interested in studying participants ranging from 10 to 17 years of age. Patients below the legal age are represented by 41 studies and there are 374 for those above 65."

Answered by AI

What are the entry criteria for participating in this research project?

"This trial is open to young people aged 10-17 who suffer from chronic pain. The study has a capacity of 25 individuals in total."

Answered by AI

What end results do researchers anticipate from this trial?

"This clinical trial has been designed to assess the acceptability of the intervention, by conducting qualitative interviews over an 8-week period. Secondary objectives include using a Patient Global Impression of Change (PGIC) Scale, Brief Pain Inventory Short Form (BPI), and Pediatric PainSCAN tool for screening nerve pain and Complex Regional Pain Syndrome in children and teens to measure severity of their condition."

Answered by AI

To what extent is the patient population being serviced by this experimental program?

"Affirmative. Information found on clinicaltrials.gov indicates that the recruitment phase for this medical trial began on October 16th 2023 and was concluded on November 16th 2023, with 25 participants needed from 1 location."

Answered by AI

Recent research and studies

PainJournal

The Chronic Pain Acceptance Questionnaire: Confirmatory Factor Analysis and Identification of Patient Subgroups

Vowles, Kevin E., Lance M. McCracken, Charlotte McLeod, and Christopher Eccleston. 2008. “The Chronic Pain Acceptance Questionnaire: Confirmatory Factor Analysis and Identification of Patient Subgroups”. Pain. Ovid Technologies (Wolters Kluwer Health). doi:10.1016/j.pain.2008.08.012.

PLoS ONEJournal

The Multidimensional Assessment of Interoceptive Awareness (MAIA)

Mehling, Wolf E., Cynthia Price, Jennifer J. Daubenmier, Mike Acree, Elizabeth Bartmess, and Anita Stewart. 2012. “The Multidimensional Assessment of Interoceptive Awareness (MAIA)”. Edited by Manos Tsakiris. Plos ONE. Public Library of Science (PLoS). doi:10.1371/journal.pone.0048230.

Journal of Pediatric PsychologyJournal

Pain Acceptance in Adolescents: Development of a Short Form of the CPAQ-A

Gauntlett-Gilbert, Jeremy, Batool Alamire, and Geoffrey B Duggan. 2018. “Pain Acceptance in Adolescents: Development of a Short Form of the CPAQ-A”. Journal of Pediatric Psychology. Oxford University Press (OUP). doi:10.1093/jpepsy/jsy090.

clinicaltrials.govStudy